A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond
Friday, September 5, 2014
What should happen, happened!
The FDA has approved Pembrolizumab in advanced and metastatic Melanoma
No comments:
Post a Comment